newsfilter
← Latest News
ACCESS Newswire·

CureVac Announces Voting Results of General Meeting

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 24, 2024 / CureVac N.V. , a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger